Search the Community

I can't believe I just found this and I can't believe the scam is so good, it's even been kept from the doctors. Had one tell me today that it was just a theory and dismissed it. Anyway... 50+ male, disabled veteran (Army) 1999 - I have symptoms that indicate pre-diabetes, but my doctor diagnosed anxiety and give me this magic little 10mg pull called Lexapro. It initially makes me feel great, but the symptoms I told my doc about persisted. Not many years later I would be diagnosed diabetic type 2. 2021 - Over 20 years of a rollercoaster of different SSRIs, temporary ups, deep dark downs, and several hospitalizations I took dramatic steps. I microdosed psilocybin using the Fadiman Protocol to help me weather withdrawal. Little did I know that psilocybin is a seratonin receptor agonist and I was helping myself neurochemically by accident. I was so messed up when I started that I don't know how long it's been. 6-10 months? 2022 - My mind is clearer than it has been in a while, but I have a way to go. My primary care doc is on board and says it's like my body chemistry is resetting. It's wreaking havoc on me physically and I know my mind is still recovering, but I'm ready to start this next phase of this adventure.

Congress Proposes Research on the Link Between Psychiatric Drugs and Suicide By Chuck Ruby, PhD Featured Blogs March 30, 2016 Congressman David Jolly (FL-13) has recently introduced the Veteran Suicide Prevention Act (H.R. 4640). The bill calls for the VA to study veteran suicides over the past five years and to determine what extent psychiatric drugs are implicated in those suicides. The International Society of Ethical Psychology and Psychiatry (ISEPP) has long been concerned about this issue, and more broadly, how our veterans and military members suffering from the horrors of war and other traumatic experiences are being treated. I sent letters of support to Mr. Jolly’s office, offering ISEPP’s assistance in any way possible. In 2012, ISEPP launched “Operation Speak Up” (OSU) as a response to the alarmingly high suicide rate of veterans. The name signifies our desire to help veterans speak up, rather than being shut up with psychiatric drugs. Although it started as an effort to encourage Congress to consider a non-medical model approach to helping those suffering from trauma, it quickly turned into a grassroots and consumer focused endeavor from the ground up under the leadership of our OSU Director, Mary Vieten, Ph.D., ABPP, U.S. Naval Reserve Commander. Mary has since made great strides in partnering with Melwood, Inc., a non-profit organization dedicated to helping people with disabilities in the greater Washington DC area. Together with Melwood’s support and funding, Mary has created a program called TOHIDU (a Cherokee word meaning “peace of mind, body, and spirit”) as a wonderful alternative to conventional treatment. You can see more about TOHIDU here. Mr. Jolly’s bill will be the first to establish congressional oversight of this alarming problem of using psychiatric drugs shotgun style to quiet the screams of trauma. Despite the increasing concerns of the deleterious effects of psychiatric drugs, they continue to be the mainstay form of treatment within the VA and Defense Department, as they are on the outside. This has to change.The extant research makes it abundantly clear that psychiatric drugs do not correct chemical imbalances. It would be better said that they cause chemical imbalances. They artificially alter brain chemistry in ways that are not clearly understood, and that numb important emotions that signal meaningful issues in our lives. The brain tries to counteract their effect by making changes in how neurotransmitters are used. The person experiences these changes in very agonizing ways, the most worrisome is called “akathisia,” or a state of agitation, restlessness, and a terrible sense of not feeling welcome in one’s own skin. This can lead to unpredictable irritability and violent behavior, including violence toward oneself. To read more on this, see ISEPP’s White Paper. More here: http://www.madinamerica.com/2016/03/congress-proposes-research-on-the-link-between-psychiatric-drugs-and-suicide/ Also on that page is information about how to contact Congress to express your support for this bill. It would be a great idea to also encourage them to investigate the suicide-drug link in other populations too!